Figure 3.
Death-censored graft survival among (A) 438 pre-sensitized recipients (panel reactivity > 0%) and (B) 229 recipients with treated rejection during the first-post-transplant year, in relation to FCGR3A-V/F158 genotype.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.